Literature DB >> 11950821

Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.

F Trevisani1, E Castelli, F G Foschi, M Parazza, E Loggi, M Bertelli, C Melotti, M Domenicali, G Zoli, M Bernardi.   

Abstract

BACKGROUND: Cirrhotic patients show increased susceptibility to bacterial infections. It is not known whether tuftsin deficiency, which is associated with an increased incidence of infections in many disease states, is present in cirrhosis. Our aims were to determine whether tuftsin activity is deficient in cirrhosis and if so, whether this deficiency is related to splenic function, contributes to altered neutrophil granulocyte function, or influences the occurrence of bacterial infections and patient survival.
METHODS: Tuftsin activity and splenic function were assessed in 31 patients with liver cirrhosis and 31 healthy subjects. The phagocytic activity of neutrophil granulocytes from 23 patients was tested in vitro with addition of both autologous and pooled sera from healthy subjects. In 10 patients and eight controls it was also tested with addition of synthetic tuftsin. Patients were followed up until death or liver transplantation.
RESULTS: Patients had reduced tuftsin activity (median 8% (range 3-24.5)) compared with controls (17% (11.5-37)) (p<0.001) and a higher pitted red cell count (p<0.001). Tuftsin activity was correlated with pitted cell count (p=0.02) and the Child-Pugh score (p=0.002). Nineteen of 23 patients showed deficient phagocytic activity of neutrophil granulocytes, which was correlated with tuftsin activity (p<0.001), improved in all cases but one with addition of serum from healthy subjects, and normalised with addition of synthetic tuftsin. Reduced tuftsin activity did not influence patient survival but was associated with a higher incidence of bacterial infections (p=0.029). COMMENT: Tuftsin activity was reduced in cirrhosis, and contributed to impaired phagocytic activity of neutrophil granulocytes. Such an abnormality appears to be related to impaired splenic function and severity of cirrhosis, and probably favours the occurrence of bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950821      PMCID: PMC1773217          DOI: 10.1136/gut.50.5.707

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

2.  Tuftsin deficiency syndrome. A report of two new cases.

Authors:  A Constantopoulos; V A Najjar
Journal:  Acta Paediatr Scand       Date:  1973-11

3.  Decreased tuftsin concentrations in patients who have undergone splenectomy.

Authors:  Z Spirer; V Zakuth; S Diamant; W Mondorf; T Stefanescu; Y Stabinsky; M Fridkin
Journal:  Br Med J       Date:  1977-12-17

4.  Relationship between splenic size and splenic function.

Authors:  R C Smart; F P Ryan; C D Holdworth; F E Preston
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

5.  Simple method of assessing splenic function in coeliac disease.

Authors:  G R Corazza; A W Bullen; R Hall; P J Robinson; M S Losowsky
Journal:  Clin Sci (Lond)       Date:  1981-01       Impact factor: 6.124

6.  Splenic size and function in adult coeliac disease.

Authors:  P J Robinson; A W Bullen; R Hall; R C Brown; P Baxter; M S Losowsky
Journal:  Br J Radiol       Date:  1980-06       Impact factor: 3.039

7.  On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.

Authors:  Y Stabinsky; Z Bar-Shavit; M Fridkin; R Goldman
Journal:  Mol Cell Biochem       Date:  1980-04-18       Impact factor: 3.396

8.  Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.

Authors:  J Fierer; F Finley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Blood polymorphonuclear dysfunction in patients with alcoholic cirrhosis.

Authors:  E Feliu; M A Gougerot; J Hakim; E Cramer; C Auclair; B Rueff; P Boivin
Journal:  Eur J Clin Invest       Date:  1977-12       Impact factor: 4.686

10.  Decreased serum tuftsin concentrations in sickle cell disease.

Authors:  Z Spirer; Y Weisman; V Zakuth; M Fridkin; N Bogair
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

View more
  12 in total

Review 1.  Spontaneous bacterial peritonitis: from pathophysiology to prevention.

Authors:  Mauro Bernardi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  Protective Effects and Potential Mechanisms of Dietary Resveratrol Supplementation on the Spleen of Broilers Under Heat Stress.

Authors:  Tiantian Meng; Juying Deng; Dingfu Xiao; Muhammed Adebayo Arowolo; Chunming Liu; Liang Chen; Wei Deng; Shaoping He; Jianhua He
Journal:  Front Nutr       Date:  2022-05-16

Review 3.  Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Authors:  Ikuo Nakamura
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 4.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  Incidence of toxoplasmosis in patients with cirrhosis.

Authors:  Sebnem Ustun; Umit Aksoy; Hande Dagci; Galip Ersoz
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

6.  Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.

Authors:  Elaine Leung; Ling Guo; Jing Bu; Marie Maloof; Joseph El Khoury; Changiz Geula
Journal:  Neurobiol Aging       Date:  2009-04-05       Impact factor: 4.673

Review 7.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

8.  The diffuse reduction in spleen density: an indicator of severe acute pancreatitis?

Authors:  Guangdong Shao; Yanmei Zhou; Zengfu Song; Maitao Jiang; Xiaoqian Wang; Xiangren Jin; Bei Sun; Xuewei Bai
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

Review 9.  Causes and Consequences of Innate Immune Dysfunction in Cirrhosis.

Authors:  Katharine Margaret Irvine; Isanka Ratnasekera; Elizabeth E Powell; David Arthur Hume
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

10.  Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice.

Authors:  Hung-Cheng Tsai; Chien-Fu Hsu; Chia-Chang Huang; Shiang-Fen Huang; Tzu-Hao Li; Ying-Ying Yang; Ming-Wei Lin; Tzung-Yan Lee; Chih-Wei Liu; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin
Journal:  Cells       Date:  2020-03-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.